Diagnostic Imaging Modalities for Müllerian Anomalies: The Case for a New Gold Standard

Berger, Agatha; Batzer, Frances R.; Lev-Toaff, Anna S.; Berry-Roberts, Crystal

doi:10.1016/j.jmig.2013.10.014

Cited by 33 publications

(39 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The assessment of endometrial cavity can be performed by ultrasonography, contrasted hysterosalgingography (HSG), and diagnostic hysteroscopy (HCT) [2]. Diagnostic hysteroscopy is considered the gold standard for assessing endometrial pathologies and congenital uterine anomalies [3]; however, it is an invasive and uncomfortable procedure [4]. Compared with diagnostic hysteroscopy, saline contrast HSG is a noninvasive procedure with similar accuracy in the diagnosis of focal endometrial pathology [5].…”

mentioning

confidence: 99%

Virtual hysteroscopy: a new non invasive approach for the assessment of uterine cavity

et al. 2017

View full text Add to dashboard Cite

Endometrial pathology occurs in 40% of premenopausal women, with abnormal bleeding, uterine fibroids (30%), and polyps (30%) being the most common findings [1]. The assessment of endometrial cavity can be performed by ultrasonography, contrasted hysterosalgingography (HSG), and diagnostic hysteroscopy (HCT) [2]. Diagnostic hysteroscopy is considered the gold standard for assessing endometrial pathologies and congenital uterine anomalies [3]; however, it is an invasive and uncomfortable procedure [4]. Compared with diagnostic hysteroscopy, saline contrast HSG is a noninvasive procedure with similar accuracy in the diagnosis of focal endometrial pathology [5]. Three-dimensional (3D) hysterosalpingo-contrast sonography (HyCoSy) that associates second-generation agents, such as SonoVue, with new software (Coded contrast imaging; GE Healthcare, Zipf, Austria) allows detailed assessment of the uterine cavity and fallopian tube patency [6].We propose a virtual hysteroscopy from 3D saline and 3D HyCoSy scan data to generate a virtual reality as a new noninvasive procedure for assessing the uterine cavity in uterine congenital anomaly and endometrial pathology cases as well as the fallopian tube patency.A 25-year-old woman with pain in the lower abdomen-type colic that increased in intensity in the last menstrual period was examined. Her menarche was at 14 years of age, and with regular menstrual periods. She had to two previous pregnancies with one term labor and one miscarriage without curettage. A 3D HyCoSy was performed with a Voluson E6 apparatus (GE, Healthcare, Milwaukee, WI, USA) equipped with an endovaginal probe (RIC 5-9D). Initially, a specific catheter for HSG (5-Fr) with a silicone balloon (1.5 mL) (Cook Medical, Spencer, IN, USA) was introduced into the cervical canal and inflated with 3-mL distilled water. In sequence, the protocol-coded contrast imaging mode was activated, AbstractEndometrial pathology is frequent in premenopausal women and the diagnostic hysteroscopy is considered the gold standard for assessing endometrial cavity and congenital uterine anomalies. However it is an invasive and uncomfortable procedure. Saline contrast hysterosalgingography and hysterosalpingo-contrast sonography allow detailed assessment of the uterine cavity. We propose a virtual hysteroscopy from three-dimensional saline and three-dimensional hysterosalpingo-contrast sonography scan data to generate a virtual reality as a new noninvasive procedure for assessing the uterine cavity in uterine congenital anomaly and endometrial pathology cases as well

show abstract

mentioning

confidence: 99%

Virtual hysteroscopy: a new non invasive approach for the assessment of uterine cavity

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Karyotyping/chromosome analysis, laparoscopic examination, hormonal status and ultrasonography provide the physicians an insight into the complexity of the anatomical defect in the MRKH syndrome patients (ACOG, 2006(ACOG, , 2013. Further, patients may undergo magnetic resonance imaging (MRI) of the pelvis, ultrasound examination of vagina, or ovarian biopsy for further investigations (Valappil et al, 2012;Bermejo et al, 2010;Rousset et al, 2013;Berger et al, 2014).…”

Section: Types and Classificationmentioning

confidence: 99%

“…Depending on their abnormalities, MRKH syndrome patients are usually listed in one of the following four classification systems: (1) European Society of Human Reproduction and Embryology (ESHRE) and the European Society for Gynecological Endoscopy (ESGE) classification (ESHRE/ESGE) (Berger et al, 2014;Grimbizis et al, 2013); (2) Vagina, Cervix, Uterus, Adnex and associated Malformation (VCUAM) classification (Berger et al, 2014;Oppelt et al, 2007;Walther, 2011); (3) American Fertility Society/American Society of Reproductive Medicine (AFS/ASRM) classification (Bermejo et al, 2010;Berger et al, 2014;AFS, 1988;Grimbizis and Campo, 2010); and (4) Embryological-Clinical classification systems (Grimbizis and Campo, 2010;Acién et al, 2004;Acien and Acien, 2011) (Table 1). This categorization helps in evaluating the patient's diagnosis and treatment options.…”

Section: Types and Classificationmentioning

confidence: 99%

Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome: A historical perspective

Patnaik

Brazile

Dandolu

et al. 2015

Gene

View full text Add to dashboard Cite

“…Urogenital sinus develops and lack of exposure to androgens allows regression of wolffian ducts and further development of m€ ullerian ducts [12][13][14] M€ ullerian ducts fuse with urogenital sinus [15][16][17][18][19][20][21][22][23][24][25][26] Cephalic growth of sinovaginal bulb occurs [15][16][17][18][19][20][21][22][23][24][25][26] After cephalic growth occurs, fusion of sinovaginal bulb will help form the vaginal plate. Subsequently, canalization of the vagina occurs.…”

Section: Primary Amenorrhea Due To An Obstructed Anomalymentioning

confidence: 99%

“…There is a higher rate of endometriosis, hematosalpinx, and pelvic inflammatory disease in these patients, due to the obstruction, so accurate diagnosis and surgical treatment or suppression is indicated. 23,25,26 …”

Section: Treatmentmentioning

confidence: 99%